Physician profile
Ryan Mui
NPI 1447817911
$976.20
in general payments reported to CMS, 2019-2025
16 companies · $76.44 in 2025
The $76.44 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $100 · 2021: $96.14 · 2022: $208 · 2023: $258 · 2024: $237 · 2025: $76.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $194.74 | 2021-2023 | |
| Madrigal Pharmaceuticals | $145.45 | 2024-2025 | Rezdiffra, Resmetirom |
| Boston Scientific Corporation | $128.97 | 2024 | Exalt Model D |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.13 | 2022-2025 | Xifaxan |
| Allergan, INC. | $86.71 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $64.02 | 2022-2025 | Dupixent |
| Pfizer INC. | $59.95 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $32.63 | 2021 | |
| Merck Sharp & Dohme LLC | $29.02 | 2020-2023 | Dificid |
| Alexion Pharmaceuticals, INC. | $24.96 | 2022 | |
| Antares Pharma, INC. | $18.54 | 2022 | |
| Ironwood Pharmaceuticals, INC | $17.80 | 2023 | Linzess |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.91 | 2022 | |
| Nestle Healthcare Nutrition INC. | $15.73 | 2022 | |
| Aurinia Pharma U.S., INC. | $13.17 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.